Anticancer and bioactivity effect of the AraA-IL13 fusion protein on the glioblastoma cell line

• Asıl Yazarlar: Rezvan Mehrab (Yazar), Hamid Sedighian (Yazar), Fattah Sotoodehnejadnematalahi (Yazar), Raheleh Halabian (Yazar), Abbas Ali Imanifooladi (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Wolters Kluwer Medknow Publications, 2024-08-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Background and purpose: Glioblastoma (GBM) is an aggressive and malignant brain cancer with the highest mortality and low survival rates. To discover a more specific and efficient treatment for GBM, we synthesized and examined the cytotoxic effect of arazyme-interleukin-13 (Ara-IL13) fusion protein...